Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failure

Nephrol Dial Transplant. 2023 Jul 31;38(8):1912-1914. doi: 10.1093/ndt/gfad058.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antiviral Agents* / therapeutic use
  • COVID-19* / complications
  • COVID-19* / therapy
  • Humans
  • Hydroxylamines / therapeutic use
  • Kidney Failure, Chronic* / complications
  • Renal Insufficiency, Chronic* / complications
  • Ritonavir / therapeutic use

Substances

  • Antiviral Agents
  • Hydroxylamines
  • molnupiravir
  • Ritonavir